News / 
FDA Cites Possible Suicide Link in Use of Paxil

FDA Cites Possible Suicide Link in Use of Paxil

Posted - Jun. 19, 2003 at 3:52 p.m.



This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON (AP) -- No one under age 18 should be prescribed the drug Paxil for major depression because the adult anti-depressant may increase a child's risk of suicide, the government said Thursday.

The Food and Drug Administration's recommendation came a week after Britain issued an even stronger warning against pediatric use of Paxil, sold there under the name Seroxat.

Children and teenagers already taking Paxil should not suddenly stop the pills, the FDA stressed. Some doctors may feel the drug is helping enough to keep a particular patient on the drug, which the FDA warning doesn't forbid. Those who do stop taking Paxil need medical supervision to avoid rebound side effects, the agency warned.

Paxil is approved for adult treatment of a number of psychiatric illnesses, including depression. While there have been lawsuits alleging Paxil caused violent or suicidal reactions, the FDA said Thursday there is no scientific evidence linking the drug to increased suicide risk among adults.

The FDA has never approved use of Paxil in children or teens. But some doctors prescribe the adult drug for children anyway.

The FDA had asked all makers of adult antidepressants to submit research showing how their drugs affect children. Three studies of Paxil found it didn't seem to help pediatric depression -- but FDA scientists spotted some safety concerns and ordered manufacturer GlaxoSmithKline to reanalyze the data.

That reanalysis -- submitted last month, first to the British government and then to FDA -- found the risk of suicidal thoughts and suicide attempts was three times greater among Paxil users, mostly teens, than among children given dummy pills, the FDA said.

There were no deaths during the studies, but FDA officials wouldn't release the actual number of suicide attempts, citing manufacturer confidentiality.

GlaxoSmithKline did not return a phone call Thursday, but the company last week said the rate of all "emotional side effects," ranging from mood swings to suicide attempts, totaled 3.2 percent of pediatric Paxil patients compared with 1.5 percent of those given dummy pills.

The FDA cautioned that it still is investigating and hasn't definitively concluded there is a suicide risk to pediatric patients.

"There is no definitive action or even decision about what ought to be done," said FDA's Dr. Russell Katz. But "we wanted to let people know" about the possible risk.

Why would Paxil cause such a side effect in children but not adults?

The FDA said it's not clear, but noted that childhood depression itself is different from adult depression, probably because of changes the child's brain undergoes as it grows. A number of adult antidepressants have failed to work in children. Plus, children often suffer different side effects from a variety of medications than adults do.

There is one FDA-approved treatment for depression in children, the competing drug Prozac. ------

(Copyright 2003 by The Associated Press. All Rights Reserved.)

SIGN UP FOR THE KSL.COM NEWSLETTER

Catch up on the top news and features from KSL.com, sent weekly.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

KSL Weather Forecast